Necessary documents for ordering:<ol><li>Order form (<A HREF="https://mus.brc.riken.jp/ja/wp-content/uploads/form/form_4.docx">Japanese</A> / <A HREF="https://mus.brc.riken.jp/en/wp-content/uploads/form/form_b.docx">English</A>)</li><li>Category I MTA: MTA for distribution with RIKEN BRC (<A HREF="https://mus.brc.riken.jp/ja/wp-content/uploads/form/form_5.docx">Japanese</A> / <A HREF="https://mus.brc.riken.jp/en/wp-content/uploads/form/form_c.docx">English</A>)</li><li>Acceptance of responsibility for living modified organism (<A HREF="https://mus.brc.riken.jp/ja/wp-content/uploads/form/form_7.docx">Japanese</A> / <A HREF="https://mus.brc.riken.jp/en/wp-content/uploads/form/form_g.docx">English</A>)</li></ol> RBRC06219 Frmpd1 gene knockout mice. Exons 3 and 4 were replaced with a PGK-neo cassette. Homozygous mutant mice are viable and fertile. true Furukawa Takahisa <a href='https://brc.riken.jp/mus/pcr06219'>Genotyping protocol -PCR-</a> C（3〜6か月） JM8 [C57BL/6N] 大阪大学蛋白質研究所・大森義裕、古川貴久（2012）。JM8 ES細胞を用いて作出。 human PGK promoter, SV40 SV40 poly A signal, E. coli Neo In publishing the research results to be obtained by use of the BIOLOGICAL RESOURCE, an acknowledgment to the DEPOSITOR is requested. Prior to requesting the BIOLOGICAL RESOURCE, the RECIPIENT must contract an MTA with the DEPOSITOR (Osaka University). C (3-6 months) Frmpd1遺伝子のノックアウトマウス。Frmpd1遺伝子はFREMドメインとPDZドメインをもつ足場タンパク。エクソン3と4をPGK-neoカセットで置換。ホモマウスは生存性、妊性あり。 古川　貴久 C57BL/6-Frmpd1<tm1Tfur> Frmpd1, B6-Frmpd1 KO Frmpd1, B6-Frmpd1 KO C57BL/6-Frmpd1<tm1Tfur> 条件を付加する。<br>研究成果の公表にあたって謝辞の表明を必要とする。<br>利用者は、事前に寄託者の提供承諾（大阪大学とのMTA締結）を得る。 Homozygote x Homozygote [or Crossing to C57BL/6NTac] Homozygote x Homozygote [or Crossing to C57BL/6NTac] Developed by Yoshihiro Omori and Takahisa Furukawa, Institute for Protein Research, Osaka University in 2012. JM8 ES cells were used.